AbbVie knows how to plan ahead.
The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?
Seeking to replace blockbuster drugs that will soon lose patent protection, drug-maker AbbVie purchased a biotech firm for ...
AbbVie said on Monday it would buy Apogee Therapeutics for $10.9 billion, the company's largest buyout in more than five ...
For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to ...
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instruction can ...
The state will still allow lethal injection for death-row prisoners if it's not possible to use the firing squad.
The FDA has approved a prefilled injection device for adults with polycythemia vera, according to a press release. The ...
The continued evolution of SARS-CoV-2 variants that evade immunity highlights a need to develop vaccines that elicit variant-specific antibodies and neutralize emerging strains. However, immune ...
Steroids, specifically corticosteroids, work by reducing inflammation that puts pressure on nerves and causes back pain. They lower levels of prostaglandins and other chemicals involved in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results